Get the Stockscreener App
1.09
1.87%
0.02
Pds Biotechnology Corporation stock is traded at $1.09, with a volume of 221.88K.
It is up +1.87% in the last 24 hours and down -10.66% over the past month.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
See More
Previous Close:
$1.07
Open:
$1.08
24h Volume:
221.88K
Relative Volume:
0.44
Market Cap:
$49.82M
Revenue:
-
Net Income/Loss:
$-40.56M
P/E Ratio:
-0.9316
EPS:
-1.17
Net Cash Flow:
$-35.28M
1W Performance:
-7.63%
1M Performance:
-10.66%
6M Performance:
-33.54%
1Y Performance:
-66.25%
1-Day Range:
$1.02
$1.09
1-Week Range:
$1.02
$1.21
52-Week Range:
$0.8505
$4.29
Pds Biotechnology Corporation Stock (PDSB) Company Profile
Name
Pds Biotechnology Corporation
Sector
Industry
Phone
800-208-3343
Address
303A COLLEGE ROAD EAST, PRINCETON
Compare PDSB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PDSB
Pds Biotechnology Corporation
|
1.09 | 48.91M | 0 | -40.56M | -35.28M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-01-22 | Initiated | B. Riley Securities | Buy |
| Jun-28-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-10-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| May-27-20 | Initiated | Alliance Global Partners | Buy |
| Mar-09-20 | Initiated | Noble Capital Markets | Outperform |
| Oct-24-19 | Initiated | Chardan Capital Markets | Buy |
View All
Pds Biotechnology Corporation Stock (PDSB) Latest News
Published on: 2025-08-02 03:00:07 - Newser
Is PDS Biotechnology Corporation reversing from oversold territoryFree Accurate Buy Point for Momentum Stocks - Newser
Why PDS Biotechnology Corporation stock attracts strong analyst attentionIntraday Price Action Forecast Planner - Newser
New Product Launches: Will They Boost PDS Biotechnology Corporation Stock in 2025Market Downturn Defense Strategy Analysis - Newser
What the charts say about PDS Biotechnology Corporation todayEquity Market Return Forecast Model Update - Newser
Smart tools for monitoring PDS Biotechnology Corporation’s price actionEquity Market Return Forecast Model Update - Newser
Long term hold vs stop loss in PDS Biotechnology CorporationStrategy Builder for Growth Focused Traders - Newser
Should I hold or sell PDS Biotechnology Corporation stock in 2025Stock Strategy Data Feed With High Returns - jammulinksnews.com
Can trapped investors hope for a rebound in PDS Biotechnology CorporationPortfolio Allocation Strategy for Stability - Newser
What does recent volatility data suggest for PDS Biotechnology CorporationFree Intraday Trend Analysis for Fast Gains - Newser
Risk adjusted return profile for PDS Biotechnology Corporation analyzedPredictive System for Long-Term Stock Forecast - Newser
Statistical indicators supporting PDS Biotechnology Corporation’s strengthProfit Target Planning with Exit Confidence - Newser
Is PDS Biotechnology Corporation a growth stock or a value stockFinancial News Planner For Consistent Profits - jammulinksnews.com
What momentum shifts mean for PDS Biotechnology CorporationProfit Target Planning with Exit Confidence - Newser
Published on: 2025-07-30 19:05:41 - beatles.ru
What Fibonacci levels say about PDS Biotechnology Corporation reboundReal-Time AI Entry Forecast Generator - Newser
PDS Biotechnology Corporation Company Revenue and Profit Trends: A Deep DiveConservative Entry for High Return Setup Backed - metal.it
Live market analysis of PDS Biotechnology CorporationStock Entry Point Planner with Volume Spike - Newser
How Resilient Is PDS Biotechnology Corporation Stock During Economic DownturnsAccurate Buy Point for Momentum Stocks Detected - metal.it
Can PDS Biotechnology Corporation Outperform Peers After Recent PullbackMarket Momentum Signal Generator Shows Trends - metal.it
Sentiment Turns Positive on PDS Biotechnology Corporation — Reversal AheadScalable Portfolio Growth Suggestions Released - metal.it
Published on: 2025-07-29 02:38:08 - metal.it
When is PDS Biotechnology Corporation stock expected to show significant growthBeginner Investor Insights That Work - jammulinksnews.com
How does PDS Biotechnology Corporation generate profit in a changing economyInvest in high-yield stocks with confidence - jammulinksnews.com
How Interest Rate Changes Impact PDS Biotechnology Corporation Stock PerformanceDouble Profit With Half Risk - Newser
What is the dividend policy of PDS Biotechnology Corporation stockMaximize your returns with portfolio optimization - jammulinksnews.com
What is the risk reward ratio of investing in PDS Biotechnology Corporation stockAchieve breakthrough results with expert guidance - jammulinksnews.com
What are PDS Biotechnology Corporation company’s key revenue driversCapitalize on momentum-driven stocks - jammulinksnews.com
What makes PDS Biotechnology Corporation stock price move sharplyMaximize returns with strategic portfolio planning - jammulinksnews.com
How many analysts rate PDS Biotechnology Corporation as a “Buy”Massive profits - jammulinksnews.com
What catalysts could drive PDS Biotechnology Corporation stock higher in 2025Exceptional trading performance - jammulinksnews.com
What are the latest earnings results for PDS Biotechnology CorporationDiscover undervalued stocks ready to soar - jammulinksnews.com
Has PDS Biotechnology Corporation Stock Ever Crashed Historical Volatility ReviewMulti Bagger Alerts - Newser
Pds Biotechnology Corporation Stock (PDSB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):